In-Vivo Patient-Specific Optimization of Transcatheter-Edge-to-Edge Repair in Mitral Regurgitation
二尖瓣反流经导管边对边修复的体内患者特异性优化
基本信息
- 批准号:10751196
- 负责人:
- 金额:$ 3.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Adverse effectsAgeBehaviorBiological MarkersBiomechanicsBlindedBloodCalibrationCardiomyopathiesCardiovascular DiseasesCharacteristicsClinicalClinical TrialsClipComplexComputer ModelsContractsDataData SetDatabasesDiseaseElementsEtiologyExtravasationGeometryGrowthHeartHeterogeneityHumanImageIschemiaLeadLeft atrial structureLeft ventricular structureLinkLungMethodsMitral ValveMitral Valve InsufficiencyMyocardial InfarctionNatureOperative Surgical ProceduresOutcomePatient imagingPatient-Focused OutcomesPatientsPopulationPositioning AttributePostoperative PeriodProceduresProcessPrognostic FactorPropertyRaceRadialRecurrenceReportingSelection for TreatmentsShapesStressTechniquesTestingTherapeuticThree-Dimensional EchocardiographyTimeTissuesTreatment EfficacyTreatment outcomeVariantWorkcase-by-case basisclinical imagingcohortcomputational pipelinesexperienceimaging modalityimprovedin silicoin vivoinsightmechanical loadnoveloutcome predictionpatient populationpatient stratificationpostoperative statepre-doctoralpreoperative staterepair modelrepairedsexsimulationsuccessthree-dimensional modelingtreatment optimizationtreatment strategytrial comparing
项目摘要
PROJECT SUMMARY
Mitral regurgitation (MR) is a prevalent and deadly disease characterized by the inability of the mitral
valve (MV) leaflets to coapt properly, permitting backflow of blood from the left ventricle into the left
atrium. The etiologies of MR are complex and diverse, ranging from myxomatous degeneration of the
valvular tissue to myocardial infarction to non-ischemic cardiomyopathy. Several types of treatment are
available, but the efficacy of these interventions remains suboptimal and unpredictable. One of these
options is the relatively recent transcatheter edge-to-edge leaflet clipping technique called the MitraClip
procedure (or TEER). Though the procedure is safe, its outcomes in clinical trials, particularly compared
to other surgical and therapeutic treatments, have been highly contradictory, largely due to the
multifactorial nature of MR. Therefore, it is clear that a predictive approach to treatment selection that
accounts for patient specific variations in MV shape and deformation is necessary to optimize long-
term patient outcomes. Our group has developed a noninvasive, image-based method for in vivo MV
strain estimation which allows us to quantify MV shape and deformation directly from clinically available
imaging data. We have also previously demonstrated that this technique can be used to identify
predictive, presurgical factors of repair efficacy for ischemic MR patients undergoing undersized ring
annuloplasty. However, previous work by our lab and others has focused on limited subsets of MR
patients; in order to develop a comprehensive treatment selection guide, simulations must be grounded
in a robust understanding of the altered MV biomechanical state in the full range of MR etiologies.
Furthermore, the effects of the highly non-physiological focal stress of the MitraClip on the immediate
and long-term shape and deformation of the MV leaflets remains almost completely unknown. We will
additionally develop a fully predictive finite element simulation of the TEER procedure in order to
preoperatively test various MitraClip scenarios directly on a 3D model of the patient's MV apparatus,
use our understanding of the MV functional state to predict the 12-month outcomes of each
configuration, and select the most optimal option. Therefore, in this study, we aim to (1) establish the
pre-operative state of the MV across the MR spectrum and (2) elucidate and predict the consequences
of the MitraClip on MV leaflet geometry, behavior, and remodeling in order to explain and ultimately
predict the outcomes of this treatment in a patient-specific and quantitative manner.
项目摘要
二尖瓣反流(MR)是一种普遍的致命疾病,其特征是二尖瓣
瓣膜(MV)传单正确地co仪,允许血液从左心室的回流向左
中庭。 MR的病因是复杂而多样的,范围从
瓣膜组织到心肌梗死至非缺血性心肌病。几种类型的治疗是
可用,但是这些干预措施的功效仍然是最佳和不可预测的。其中之一
选项是相对较新的经导管边缘到边缘传单剪切技术,称为Mitraclip
程序(或TEER)。尽管该程序是安全的,但其在临床试验中的结果,特别是比较
对于其他外科手术和治疗性治疗,这是高度矛盾的,主要是由于
MR的多因素性质。因此,很明显,一种预测的治疗方法
为了优化长期,需要计算患者特定于MV形状和变形的变化
术语患者的结果。我们的小组开发了一种基于图像的无创的方法,用于体内MV
应变估计,使我们可以直接从临床上量化MV形状和变形
成像数据。我们以前还证明,该技术可用于识别
缺血性MR患者的预测性修复疗效的预性因素
环形成形术。但是,我们的实验室和其他人的先前工作重点是MR的有限亚集
患者;为了制定全面的治疗选择指南,必须将模拟接地
在整个MR病因范围内,对MV生物力学状态改变的强烈理解。
此外,mitraclip高度非生理局灶性应力对立即的影响
MV小叶的长期形状和变形几乎完全未知。我们将
另外,为TEER程序开发了完全预测的有限元模拟,以便
术前直接在患者MV设备的3D模型上测试各种Mitraclip方案,
利用我们对MV功能状态的理解来预测每个功能的12个月结果
配置,然后选择最佳选项。因此,在这项研究中,我们的目标是(1)建立
MV跨MR光谱的术前状态,(2)阐明并预测后果
MV传单几何形状,行为和重塑的MITraclip,以解释并最终
以患者特异性和定量方式预测这种治疗的结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Natalie Simonian其他文献
Natalie Simonian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
随机噪声影响下具有年龄结构的布鲁氏菌病动力学行为与最优控制研究
- 批准号:12201330
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
随机噪声影响下具有年龄结构的布鲁氏菌病动力学行为与最优控制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
几类年龄结构种群和传染病模型的动力学行为与控制问题研究
- 批准号:12101323
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
几类年龄结构种群和传染病模型的动力学行为与控制问题研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
减少年轻成年睾丸癌幸存者不良后果的生物行为干预
- 批准号:
10736501 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Sex-specific Impact of Prenatal Opioids on Brain Reward Signaling and Neonatal Feeding Regulation
产前阿片类药物对大脑奖赏信号和新生儿喂养调节的性别特异性影响
- 批准号:
10506345 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Outcome of Neurological Disorders in Adults Exposed to Moderate Levels of Alcohol in Utero
子宫内接触适量酒精的成人神经系统疾病的结果
- 批准号:
10655859 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Psychobiological Mechanisms Underlying the Association Between Early Life Stress and Depression Across Adolescence
早期生活压力与青春期抑郁之间关联的心理生物学机制
- 批准号:
10749429 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别: